SCHEMBL4803769

SCHEMBL4803769

Fc1cccc(COc2ncc(-c3ccc(C=S)cc3Cl)c(-c3ccc(Cl)cc3)n2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
HPGD P15428 3/20 0.38
CYP1A2 P05177 3/20 0.38
KDM4E B2RXH2 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
PKM P14618 1/20 0.38
CNR1 P21554 11/20 0.38
USP2 O75604 2/20 0.36
LMNA P02545 2/20 0.36
HSD17B10 Q99714 2/20 0.36
ALOX5 P09917 1/20 0.36
ALOX5AP P20292 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CNR2 P34972 2/20 0.35
MALT1 Q9UDY8 1/20 0.35
MAOA P21397 1/20 0.34
MAOB P27338 1/20 0.34
CASP1 P29466 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4812927 0.93 CNR1 (0.44) CNR1CNR2
SCHEMBL4808893 0.89 CNR1 (0.46) ALDH1A1HPGDCYP1A2KDM4ECYP3A4
SCHEMBL4807899 0.89 CNR1 (0.47) ALDH1A1HPGDCYP1A2CNR1USP2
SCHEMBL4811618 0.88 ALDH1A1 (0.39) ALDH1A1HPGDCYP1A2CYP3A4CNR1
SCHEMBL4803775 0.85 CNR1 (0.39) ALDH1A1HPGDCYP1A2KDM4ECYP3A4
SCHEMBL14107191 0.83 CNR1 (0.40) ALDH1A1HPGDCYP1A2KDM4ECYP3A4
SCHEMBL4810400 0.81 CNR1 (0.53) CNR1CNR2
SCHEMBL4806722 0.81 CNR1 (0.52) CNR1CNR2
SCHEMBL4802335 0.81 CNR1 (0.54) ALDH1A1HPGDCYP1A2KDM4ECNR1
SCHEMBL4811912 0.80 CNR1 (0.44) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405221-B2 Substituted pyrimidines MERCK & CO., INC. (US) 2008-07-29 US disclosed
US-20050245554-A1 Substituted pyrimidines MERCK SHARP & DOHME CORP. 2005-11-03 US disclosed
EP-1546115-A2 SUBSTITUTED PYRIMIDINES Merck & Co., Inc. (US) 2005-06-29 EP disclosed
WO-2004029204-A2 SUBSTITUTED PYRIMIDINES MERCK & CO., INC. (US) 2004-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050245554-A1 Substituted pyrimidines CNR1, CNR2, GPR119 ALDH1A1 3049/4885HPGD 2626/4885CYP1A2 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.